Clavulanic acid is an orally available and potent mechanism-based β-lactamase inhibitor. In combination with β-lactam antibiotic clavulanic acid can overcome antibiotic resistance in bacteria that produce β-lactamase. Clavulanic acid is produced by Streptomyces clavuligerus.
Orally available and potent mechanism-based β-lactamase inhibitor
Caution
Hygroscopic
Storage Class Code
11 - Combustible Solids
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Choose from one of the most recent versions:
Certificates of Analysis (COA)
Lot/Batch Number
It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.
Penicillin-Binding Proteins, ?-Lactamases, and ?-Lactamase Inhibitors in ?-Lactam-Producing Actinobacteria: Self-Resistance Mechanisms
International Journal of Molecular Sciences, 23(10), 5662-5662 (2022)
In vitro Antibacterial Activity and Resistance Prevention of Antimicrobial Combinations for Dihydropteroate Synthase-Carrying Stenotrophomonas maltophilia
Infection and Drug Resistance, 15, 3039-3046 (2022)
Antimicrobial agents and chemotherapy, 11(5), 852-857 (1977-05-01)
A novel beta-lactamase inhibitor has been isolated from Streptomyces clavuligerus ATCC 27064 and given the name clavulanic acid. Conditions for the cultivation of the organism and detection and isolation of clavulanic acid are described. This compound resembles the nucleus of
Questions
Reviews
★★★★★ No rating value
Active Filters
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
